The Worldwide Robotic Vascular Catheter System Industry is Expected to Reach $541.1 Million in 2028 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Robotic Vascular Catheter System Market Size, Share, & COVID-19 Impact Analysis 2022-2028 - MedCore - Includes: Capital Equipment, and 3 more" report has been added to ResearchAndMarkets.com's offering.

The global robotic vascular catheter system market was valued at $213.2 million in 2021. Over the forecast period, this is anticipated to increase at a CAGR of 14.2% to reach $541.1 million.

The full report suite on the global market for robotic vascular catheter systems consists of three main segments: capital equipment, limited use accessories (LUA) and services and maintenance revenue. Regional procedure volumes using robotic catheters are also included and reported.

MARKET REPORT DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• COVID-19 Impact Analysis
• Market Drivers & Limiters
• Market Forecasts Until 2028, and Historical Data to 2018
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

PROCEDURE NUMBERS

The global robotic vascular catheter system market experienced a surge in the number of procedures performed in 2021. In 2020, the market had actually seen a reduction in procedure volume as a result of the global COVID-19 pandemic. In 2021, the procedure numbers were able to largely recover but were still lower than the reported pre-pandemic numbers.

GLOBAL ROBOTIC VASCULAR CATHETER SYSTEM MARKET TRENDS

A general trend that is being observed across all segments of the surgical robotics market is the increasing usage of robots during surgery, especially the need for surgical robots that possess the capability of performing minimally invasive surgery.

GLOBAL ROBOTIC VASCULAR CATHETER SYSTEM MARKET SHARE INSIGHTS

Overall, within the global robotic vascular catheter system market there are three dominant competitors: Auris Health, Stereotaxis, and Corindus Vascular Robotics. Auris Health, a Johnson & Johnson company, led the global robotic vascular catheter system market in 2021 through its acquisition of Hansen Medicala a few years prior. The company has a range of robotic catheters and accessories, including the MagellanT, Sensei and Artisan Extend Control Catheter systems.

GLOBAL ROBOTIC VASCULAR CATHETER SYSTEM MARKET SEGMENTATION SUMMARY

• Capital Equipment
• Limited Use Accessories (LUA)
• Services Revenue
• Maintenance Revenue

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States)
• Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
• Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
• Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
• Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
• Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
• Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
• Base Year: 2021
• Forecast Period: 2022-2028
• Historical Data: 2018-2021
• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

Companies Mentioned

• Johnson & Johnson
• Stereotaxis
• Siemens Healthineers
• Catheter Precision
• Robocath

For more information about this report visit https://www.researchandmarkets.com/r/lokn6w